Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.44 | 36.31 |
PEG Ratio (TTM) | 0.50 | 1.43 |
P/S Ratio (TTM) | 0.56 | 3.68 |
P/B Ratio (TTM) | 2.95 | 26.07 |
P/FCF Ratio (TTM) | -30.18 | 24.59 |
Price to 5YR AVG Earnings Ratio | -1.64 | 27.86 |
Price to 5YR AVG FCF Ratio | -5.55 | 26.39 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -11.76% | 8.84% |
ROE (TTM) | -118.79% | 114.99% |
Net Profit Margin (TTM) | -22.85% | 11.27% |
ROIC 5YR AVG | -15.29% | 27.63% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -499.05% | -1,279.48% | -816.72% |
Revenue | -5.58% | 46.08% | 37.54% |
Net Income | -496.01% | -1,094.52% | -699.63% |
Cash Flow | -59.08% | -218.22% | -162.03% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.49 | 1.00 |
Quick Ratio (TTM) | 5.47 | 0.73 |
D/E Ratio (TTM) | 8.02 | 3.26 |
Interest Coverage (TTM) | -11.36 | 26.24 |
Piotroski F-Score | 5 | 8 |
Altman Z-Score | 0.14 | 5.45 |
LTL to 5YR AVG FCF | -20.04 | 2.51 |
Shares Outstanding Growth 5YR AVG | 32.77% | -0.95% |